Patents by Inventor Andrew David Cook

Andrew David Cook has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OSTEOARTHRITIS TREATMENT
    Publication number: 20200247895
    Abstract: The present invention relates generally to a method for the treatment and/or prophylaxis of osteoarthritis (OA). In accordance with the present invention, an antagonist of GM-CSF can be effective in the treatment of osteoarthritis. An antagonist of GM-CSF includes, but is not limited to, an antibody that is specific for GM-CSF or the GM-CSF receptor. The present invention further provides transgenic animals, such as a GM-CSF knock-out mouse, useful for testing antagonists in certain disease models.
    Type: Application
    Filed: March 31, 2020
    Publication date: August 6, 2020
    Applicant: The University of Melbourne
    Inventors: John Allan Hamilton, Andrew David Cook
  • METHOD FOR THE TREATMENT OF PAIN AND OSTEOARTHRITIS WITH C-FMS ANTAGONISTS
    Publication number: 20180237531
    Abstract: The present invention relates generally to a method for the treatment and/or prophylaxis of osteoarthritis (OA) and/or pain. In accordance with the present invention, an antagonist of c-Fms is effective in the treatment of osteoarthritis and/or pain. An antagonist of M-CSF includes, but is not limited to, an antibody that is specific for M-CSF, IL-34 or c-Fms.
    Type: Application
    Filed: April 17, 2018
    Publication date: August 23, 2018
    Inventors: Stefan STEIDL, John Allan HAMILTON, Andrew David COOK
  • Method for treatment of osteoarthritis with C-Fms antagonists
    Patent number: 10005840
    Abstract: The present invention relates generally to a method for the treatment and/or prophylaxis of osteoarthritis (OA) and/or pain. In accordance with the present invention, an antagonist of c-Fms is effective in the treatment of osteoarthritis and/or pain. An antagonist of M-CSF includes, but is not limited to, an antibody that is specific for M-CSF, IL-34 or c-Fms.
    Type: Grant
    Filed: December 16, 2015
    Date of Patent: June 26, 2018
    Assignees: MORPHOSYS AG, THE UNIVERSITY OF MELBOURNE
    Inventors: Stefan Steidl, John Allan Hamilton, Andrew David Cook
  • OSTEOARTHRITIS TREATMENT
    Publication number: 20180066062
    Abstract: The present invention relates generally to a method for the treatment and/or prophylaxis of osteoarthritis (OA). In accordance with the present invention, an antagonist of GM-CSF can be effective in the treatment of osteoarthritis. An antagonist of GM-CSF includes, but is not limited to, an antibody that is specific for GM-CSF or the GM-CSF receptor. The present invention further provides transgenic animals, such as a GM-CSF knock-out mouse, useful for testing antagonists in certain disease models.
    Type: Application
    Filed: November 13, 2017
    Publication date: March 8, 2018
    Applicant: The University of Melbourne
    Inventors: John Allan Hamilton, Andrew David Cook
  • Pain treatment
    Patent number: 9834599
    Abstract: The present invention relates generally to a method for the treatment and prophylaxis of pain. In accordance with the present invention, it is proposed that antagonists of GM-CSF are effective in the treatment of pain. Antagonists of GM-CSF include, but are not limited to, antibodies which are specific for GM-CSF or the GM-CSF receptor. The present invention further provides transgenic animals, such as a GM-CSF knock-out mouse, useful for testing antagonists in certain disease models.
    Type: Grant
    Filed: April 29, 2016
    Date of Patent: December 5, 2017
    Assignee: THE UNIVERSITY OF MELBOURNE
    Inventors: John Allan Hamilton, Andrew David Cook
  • PAIN TREATMENT
    Publication number: 20160311896
    Abstract: The present invention relates generally to a method for the treatment and prophylaxis of pain. In accordance with the present invention, it is proposed that antagonists of GM-CSF are effective in the treatment of pain. Antagonists of GM-CSF include, but are not limited to, antibodies which are specific for GM-CSF or the GM-CSF receptor. The present invention further provides transgenic animals, such as a GM-CSF knock-out mouse, useful for testing antagonists in certain disease models.
    Type: Application
    Filed: April 29, 2016
    Publication date: October 27, 2016
    Inventors: John Allan Hamilton, Andrew David Cook
  • Use of c-Fms antagonists
    Publication number: 20160185867
    Abstract: The present invention relates generally to a method for the treatment and/or prophylaxis of osteoarthritis (OA) and/or pain. In accordance with the present invention, an antagonist of c-Fms is effective in the treatment of osteoarthritis and/or pain. An antagonist of M-CSF includes, but is not limited to, an antibody that is specific for M-CSF, IL-34 or c-Fms.
    Type: Application
    Filed: December 16, 2015
    Publication date: June 30, 2016
    Inventors: Stefan Steidl, John Allan Hamilton, Andrew David Cook
  • OSTEOARTHRITIS TREATMENT
    Publication number: 20160185868
    Abstract: The present invention relates generally to a method for the treatment and/or prophylaxis of osteoarthritis (OA). In accordance with the present invention, an antagonist of GM-CSF can be effective in the treatment of osteoarthritis. An antagonist of GM-CSF includes, but is not limited to, an antibody that is specific for GM-CSF or the GM-CSF receptor. The present invention further provides transgenic animals, such as a GM-CSF knock-out mouse, useful for testing antagonists in certain disease models.
    Type: Application
    Filed: December 18, 2015
    Publication date: June 30, 2016
    Inventors: John Allan Hamilton, Andrew David Cook
  • Methods of treating pain using an antibody specific for GM-CSF
    Patent number: 9352034
    Abstract: The present invention relates generally to a method for the treatment and prophylaxis of pain. In accordance with the present invention, it is proposed that antagonists of GM-CSF are effective in the treatment of pain. Antagonists of GM-CSF include, but are not limited to, antibodies which are specific for GM-CSF or the GM-CSF receptor. The present invention further provides transgenic animals, such as a GM-CSF knock-out mouse, useful for testing antagonists in certain disease models.
    Type: Grant
    Filed: May 28, 2013
    Date of Patent: May 31, 2016
    Assignee: The University of Melbourne
    Inventors: John Allan Hamilton, Andrew David Cook
  • Use of M-CSF antibodies in the treatment of osteoarthritis or pain
    Patent number: 9243066
    Abstract: The present invention relates generally to a method for the treatment and/or prophylaxis of osteoarthritis (OA) and/or pain. In accordance with the present invention, an antagonist of c-Fms is effective in the treatment of osteoarthritis and/or pain. An antagonist of M-CSF includes, but is not limited to, an antibody that is specific for M-CSF, IL-34 or c-Fms.
    Type: Grant
    Filed: July 17, 2012
    Date of Patent: January 26, 2016
    Assignees: University of Melbourne, Morpho Sys AG
    Inventors: Stefan Steidl, John Allan Hamilton, Andrew David Cook
  • Osteoarthritis treatment
    Patent number: 9243061
    Abstract: The present invention relates generally to a method for the treatment and/or prophylaxis of osteoarthritis (OA). In accordance with the present invention, an antagonist of GM-CSF can be effective in the treatment of osteoarthritis. An antagonist of GM-CSF includes, but is not limited to, an antibody that is specific for GM-CSF or the GM-CSF receptor. The present invention further provides transgenic animals, such as a GM-CSF knock-out mouse, useful for testing antagonists in certain disease models.
    Type: Grant
    Filed: December 21, 2009
    Date of Patent: January 26, 2016
    Assignee: University of Melbourne
    Inventors: John Allan Hamilton, Andrew David Cook
  • Electric motor configured for facilitated washability
    Patent number: 9197109
    Abstract: An electric motor having a casing positioned between a head end cap and a tail end cap is provided. An output shaft passes through the head end cap and the tail end cap and a cooling fan is mounted for rotation relative to the output shaft. The electric motor includes a fluid distribution chamber adjacent the tail end cap, an inlet port for supply of fluid to the chamber, and a plurality of discharge apertures for distributing fluid from the chamber toward the cooling fan. The fluid distribution chamber facilitates the washing and cleaning of the electric motor.
    Type: Grant
    Filed: March 8, 2012
    Date of Patent: November 24, 2015
    Assignee: Stainless Motors, Inc.
    Inventors: John Christen Oleson, Andrew David Cook
  • TREATMENT OF CHRONIC INFLAMMATORY CONDITIONS
    Publication number: 20150017180
    Abstract: A method for the treatment of a chronic inflammatory condition in a patient which comprises administration to the patient of an agent which blocks or inhibits IL-3 signalling events in the patient.
    Type: Application
    Filed: May 12, 2014
    Publication date: January 15, 2015
    Applicant: CSL Limited
    Inventors: Gino Luigi Vairo, John Allan Hamilton, Andrew David Cook
  • Use of c-Fms antagonists
    Publication number: 20140205608
    Abstract: The present invention relates generally to a method for the treatment and/or prophylaxis of osteoarthritis (OA) and/or pain. In accordance with the present invention, an antagonist of c-Fms is effective in the treatment of osteoarthritis and/or pain. An antagonist of M-CSF includes, but is not limited to, an antibody that is specific for M-CSF, IL-34 or c-Fms.
    Type: Application
    Filed: July 17, 2012
    Publication date: July 24, 2014
    Applicants: MorphoSys AG, The University of Melbourne
    Inventors: Stefan Steidl, John Allan Hamilton, Andrew David Cook
  • Pain treatment
    Publication number: 20130243791
    Abstract: The present invention relates generally to a method for the treatment and prophylaxis of pain. In accordance with the present invention, it is proposed that antagonists of GM-CSF are effective in the treatment of pain. Antagonists of GM-CSF include, but are not limited to, antibodies which are specific for GM-CSF or the GM-CSF receptor. The present invention further provides transgenic animals, such as a GM-CSF knock-out mouse, useful for testing antagonists in certain disease models.
    Type: Application
    Filed: May 28, 2013
    Publication date: September 19, 2013
    Applicant: The University of Melbourne
    Inventors: John Allan Hamilton, Andrew David Cook
  • Electric Motor Configured for Facilitated Washability
    Publication number: 20130234541
    Abstract: An electric motor having a casing positioned between a head end cap and a tail end cap is provided. An output shaft passes through the head end cap and the tail end cap and a cooling fan is mounted for rotation relative to the output shaft. The electric motor includes a fluid distribution chamber adjacent the tail end cap, an inlet port for supply of fluid to the chamber, and a plurality of discharge apertures for distributing fluid from the chamber toward the cooling fan. The fluid distribution chamber facilitates the washing and cleaning of the electric motor.
    Type: Application
    Filed: March 8, 2012
    Publication date: September 12, 2013
    Applicant: STAINLESS MOTORS, INC.
    Inventors: John Christen Oleson, Andrew David Cook
  • Method of treating pain using an antagonist of GM-CSF
    Patent number: 8475796
    Abstract: The present invention relates generally to a method for the treatment and prophylaxis of pain. In accordance with the present invention, it is proposed that antagonists of GM-CSF are effective in the treatment of pain. Antagonists of GM-CSF include, but are not limited to, antibodies which are specific for GM-CSF or the GM-CSF receptor. The present invention further provides transgenic animals, such as a GM-CSF knock-out mouse, useful for testing antagonists in certain disease models.
    Type: Grant
    Filed: December 21, 2009
    Date of Patent: July 2, 2013
    Assignee: University of Melbourne
    Inventors: John Allan Hamilton, Andrew David Cook
  • Electric motor for use in hazardous environments
    Patent number: 8227947
    Abstract: An electric motor is provided that is configured for operation in hazardous or other hazardous environments. The electric motor includes a housing for a rotor and a stator. The housing includes a pair of end caps and a casing positioned therebetween. The end caps and the casing are held together using internal tie bars extending between and connected to the end caps.
    Type: Grant
    Filed: August 10, 2009
    Date of Patent: July 24, 2012
    Assignee: Stainless Motors, Inc.
    Inventors: John Christen Oleson, Andrew David Cook
  • Osteoarthritis treatment
    Publication number: 20120003234
    Abstract: The present invention relates generally to a method for the treatment and/or prophylaxis of osteoarthritis (OA). In accordance with the present invention, an antagonist of GM-CSF can be effective in the treatment of osteoarthritis. An antagonist of GM-CSF includes, but is not limited to, an antibody that is specific for GM-CSF or the GM-CSF receptor. The present invention further provides transgenic animals, such as a GM-CSF knock-out mouse, useful for testing antagonists in certain disease models.
    Type: Application
    Filed: December 21, 2009
    Publication date: January 5, 2012
    Applicant: THE UNIVERSITY OF MELBOURNE
    Inventors: John Allan Hamilton, Andrew David Cook
  • Pain treatment
    Publication number: 20110287027
    Abstract: The present invention relates generally to a method for the treatment and prophylaxis of pain. In accordance with the present invention, it is proposed that antagonists of GM-CSF are effective in the treatment of pain. Antagonists of GM-CSF include, but are not limited to, antibodies which are specific for GM-CSF or the GM-CSF receptor. The present invention further provides transgenic animals, such as a GM-CSF knock-out mouse, useful for testing antagonists in certain disease models.
    Type: Application
    Filed: December 21, 2009
    Publication date: November 24, 2011
    Applicant: THE UNIVERSITY OF MELBOURNE
    Inventors: John Allan Hamilton, Andrew David Cook